All Stories

  1. Mometasone/indacaterol/glycopyrronium (MF/IND/GLY) improves lung function and reduces exacerbations in patients with asthma, independent of baseline airflow limitation: Results from IRIDIUM study

    Article • September 2021, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas

  2. Corticosteroids in COVID-19: one size does not fit all

    Article • European Respiratory Journal, February 2021, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas, Chris Kyriakopoulos

  3. Identification and treatment of T2-low asthma in the era of biologics

    Article • ERJ Open Research, September 2020, European Respiratory Society (ERS)

    Chris Kyriakopoulos, Dr. Konstantinos Kostikas, Dr Konstantinos Panagiotis Bartziokas

  4. Artificial intelligence techniques in asthma: a systematic review and critical appraisal of the existing literature

    Article • European Respiratory Journal, May 2020, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas

  5. Health care resource utilization (HCRU) in early and late diagnosed Chronic Obstructive Pulmonary Disease (COPD) patients in UK primary care

    Article • September 2019, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas

  6. Clinical consequences of late Chronic Obstructive Pulmonary Disease (COPD) diagnosis compared to early diagnosis in UK primary care

    Article • September 2019, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas

  7. Late Breaking Abstract - Difference in clinical outcomes between smoking and non-smoking asthma patients who initiated an ICS or ICS/LABA treatment

    Article • September 2019, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas

  8. Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study

    Article • September 2019, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas

  9. Impact of COPD diagnosis timing on clinical and economic outcomes: the ARCTIC observational cohort study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2019, Dove Medical Press

    Dr. Konstantinos Kostikas, Christer Janson, Leif Jorgensen, Kjell Larsson

  10. Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2019, Dove Medical Press

    Jørgen Vestbo, Claus Vogelmeier, Dr. Konstantinos Kostikas

  11. Treatment response in COPD: does FEV1 say it all? A post hoc analysis of the CRYSTAL study

    Article • ERJ Open Research, February 2019, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas

  12. Correction

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, October 2018, Taylor & Francis

    Dr. Konstantinos Kostikas

  13. Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

    Article • American Review of Respiratory Disease, August 2018, American Thoracic Society

    Dr. Konstantinos Kostikas

  14. Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, August 2018, Dove Medical Press

    Dr Peter Kardos, Claus Vogelmeier, Dr. Konstantinos Kostikas, Nadine Lossi

  15. Early Changes in eDiary COPD Symptoms Predict Clinically Relevant Treatment Response at 12 Weeks: Analysis from the CRYSTAL Study

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, April 2018, Taylor & Francis

    Dr. Konstantinos Kostikas

  16. COPD exacerbation rates with IND/GLY

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2018, Dove Medical Press

    Claus Vogelmeier, Professor Kenneth R Chapman, Dr. Konstantinos Kostikas, Jørgen Vestbo

  17. Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

    Article • International Journal of Chronic Obstructive Pulmonary Disease, April 2018, Dove Medical Press

    Dr. Konstantinos Kostikas, Nadine Lossi, Mina Gaga, Claus Vogelmeier

  18. Blood eosinophils as biomarkers to drive treatment choices in asthma and COPD

    Article • Current Drug Targets, February 2018, Bentham Science Publishers

    Dr. Konstantinos Kostikas

  19. The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD

    Article • International Journal of Chronic Obstructive Pulmonary Disease, May 2017, Dove Medical Press

    Dr. Konstantinos Kostikas, giovanni bader, Claus Vogelmeier

  20. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis

    Article • International Journal of Chronic Obstructive Pulmonary Disease, March 2017, Dove Medical Press

    Professor David Price, Dr. Konstantinos Kostikas, giovanni bader

  21. The asthma–COPD overlap syndrome: do we really need another syndrome in the already complex matrix of airway disease?

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2016, Dove Medical Press

    Dr. Konstantinos Kostikas

  22. Early bronchodilator action of glycopyrronium versus tiotropium in moderate-to-severe COPD patients: a cross-over blinded randomized study (Symptoms and Pulmonary function in the moRnING)

    Article • International Journal of Chronic Obstructive Pulmonary Disease, June 2016, Dove Medical Press

    Dr. Konstantinos Kostikas

  23. Editorial (Thematic Issue: Biomarkers in the Management of Chronic Lung Disease)

    Article • Current Topics in Medicinal Chemistry, March 2016, Bentham Science Publishers

    Dr. Konstantinos Kostikas

  24. Cardiovascular comorbidities in hospitalised COPD patients: a determinant of future risk?

    Article • European Respiratory Journal, April 2015, European Respiratory Society (ERS)

    Dr. Konstantinos Kostikas, Dr Konstantinos Panagiotis Bartziokas